Pure and Applied Chemistry

Pure Appl. Chem., 2011, Vol. 83, No. 3, pp. 489-493

http://dx.doi.org/10.1351/PAC-CON-10-09-27

Published online 2011-01-18

Synthesis of mycalazol and mycalazal analogs with potent antiproliferating activities

References

• 1a. D. J. Newman, G. M. Cragg. J. Nat. Prod. 70, 461 (2007). (http://dx.doi.org/10.1021/np068054v)
• 1b. G. M. Cragg, D. G. I. Kingston, D. J. Newman. In Anticancer Agents from Natural Products, G. M. Cragg, D. G. I. Kingston, D. J. Newman (Eds.), p. 1, Taylor & Francis/CRC Press, Boca Raton (2005).
• 2. R. B. Silverman. The Organic Chemistry of Drug Design and Drug Action, pp. 17–87, Elsevier Academic Press, Burlington (2004).
• 3. M. J. Ortega, E. Zubia, J. L Carballo, J. Salvá. Tetrahedron 53, 331 (1997). (http://dx.doi.org/10.1016/S0040-4020(96)00989-1)
• 4. T. V. Hansen, L. Skattebøl. Tetrahedron Lett. 45, 2809 (2004). (http://dx.doi.org/10.1016/j.tetlet.2004.02.024)
• 5a. H. F. Anwar, T. V. Hansen. Org. Lett. 11, 587 (2009). (http://dx.doi.org/10.1021/ol802635a)
• 5b. T. V. Hansen, Y. Stenstrøm. Tetrahedron: Asymmetry 12, 1407 (2001). (http://dx.doi.org/10.1016/S0957-4166(01)00250-6)
• 5c. T. V. Hansen, Y. Stenstrøm. Synth. Commun. 30, 2549 (2000). (http://dx.doi.org/10.1080/00397910008087419)
• 5d. A. Vik, T. V. Hansen, A. K. Holmeide, L. Skattebøl. Tetrahedron Lett. 51, 2852 (2010). (http://dx.doi.org/10.1016/j.tetlet.2010.03.085)
• 6. S.-C. Mao, Y. Liu, B. Morgan, M. B. Jekabsons, Y.-D. Zhou, D. G. Nagle. J. Nat. Prod. 72, 1927 (2009). (http://dx.doi.org/10.1021/np900444m)
• 7. G. L. Semenza. IUBMB Life 60, 591 (2008). (http://dx.doi.org/10.1002/iub.93)
• 8. E. B. Rankin, A. J. Giaccia. Cell Death Differ. 15, 678 (2008). (http://dx.doi.org/10.1038/cdd.2008.21)
• 9. G. L. Semenza. Drug Discov. Today 12, 853 (2007). (http://dx.doi.org/10.1016/j.drudis.2007.08.006)
• 10. B. K. Nabbs, A. D. Abell. Bioorg. Med. Chem. Lett. 9, 505 (1999). (http://dx.doi.org/10.1016/S0960-894X(99)00021-9)
• 11. F. Denat, H. Gaspard-Iloughmane, J. Dubac. J. Organomet. Chem. 423, 173 (1992). (http://dx.doi.org/10.1016/0022-328X(92)83112-U)
• 12. J. M. Muchowski, P. Hess. Tetrahedron Lett. 29, 777 (1988). (http://dx.doi.org/10.1016/S0040-4039(00)80207-5)
• 13. D. Milstein, J. K. Stille. J. Am. Chem. Soc. 100, 3636 (1978). (http://dx.doi.org/10.1021/ja00479a077)
• 14. A. Rüttimann, A. Wick, A. Eschenmoser. Helv. Chim. Acta 58, 1450 (1975). (http://dx.doi.org/10.1002/hlca.19750580521)
• 15a. N. Lawrence, A. McGown, S. Ducki, J. Hadfield. Anti-Cancer Drug Des. 15, 135 (2000).
• 15b. K. Odlo, J. Hentzen, J. Fournier dit Chabert, S. Ducki, O. A. B. S. M. Gani, I. Sylte, M. Skrede, V. A. Flørenes, T. V. Hansen. Bioorg. Med. Chem. 16, 4829 (2008). (http://dx.doi.org/10.1016/j.bmc.2008.03.049)